Gilead Science, INC

Vemlidy-tafnat

"Vemlidy" contains Drug / Molecule called "Tanofovir Alafenamide". Vemlidy is a Nucleotide Reverse Transcriptase Inhibitor (NRTI) and a novel ester prodrug of the antiretroviral. Vemlidy mimics normal DNA building blocks but is lacking a 3'-OH molecule required for phosphodiester bond linkage. Vemlidy causes early chain termination and prevents proviral DNA 27 transcription.

Details
Specification

Indication

Vemlidy is used in the treatment of HIV infection and Chronic hepatitis B .

Note

Precaution

Vemlidy is a prescription drug and should be used under proper medical guidance and advice.
Treatment with Vemlidy should be suspended in any patient who develops clinical or laboratory findings suggestive of lactic acidosis or pronounced hepatotoxicity .

Updated On Nov 01, 2019 by Admin

Strength

25 mg

Packing

1 X 30 Tablets (Bottle)

Storage

Store below 30°C (86°F), Keep container tightly closed.

Was this page helpful?

☆ ☆ ☆ ☆ ☆

Not Upto Date Insufficient Helpful

Any suggestions or inputs for Shubhampharma.

Vemlidy-tafnat also available as

NATCO PHARMA LIMITED (INDIA)

Tafanat

TAFNAT contains Drug / Molecule called “Tanofovir Alafenamide”. Tafnat 25mg (Tenofovir Alafenamide -TAF) is a Nucleotide Reverse Transcriptase Inhibitor (NRTI) and a novel ester prodrug of the antiretroviral. Tenofovir alafenamide 25mg Tablets mimics normal DNA building blocks but is lacking a 3'-OH molecule required for phosphodiester bond linkage. Tafnat 25mg (Tenofovir Alafenamide -TAF) tablets causes early chain termination and prevents proviral DNA 27 transcription.